Clinical trial
Diosmiplex (Vasculera®) in Primary and Secondary Raynaud's Phenomenon
NCT02683408 is registered in ClinicalTrials.gov with Primus Pharmaceuticals as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Diosmiplex (Vasculera®) in Primary and Secondary Raynaud's Phenomenon
- Lead sponsor
- Primus Pharmaceuticals
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 29, 2016
- Completion date
- July 31, 2017
- Enrollment
- 87 (actual)
- Sites
- 11
Conditions
As the registry lists them; a condition with its own page is linked.
raynaud's disease